BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30270520)

  • 21. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13.
    Liu S; Huang M; Chen Z; Chen J; Chao Q; Yin X; Quan M
    Exp Cell Res; 2020 Apr; 389(1):111894. PubMed ID: 32035950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
    Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
    Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
    Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
    Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
    Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
    J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5.
    Jiang H; Guo Y; Huang K; Lu R; Peng X; Lin S
    J BUON; 2019; 24(6):2514-2522. PubMed ID: 31983127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
    BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
    Nakamura S; Kanda M; Koike M; Shimizu D; Umeda S; Hattori N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Omae K; Kodera Y
    Ann Surg Oncol; 2020 Jul; 27(7):2559-2568. PubMed ID: 32052303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion.
    Wang B; Liang T; Li J
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4524-4531. PubMed ID: 30058683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1.
    Ma YS; Wu TM; Lv ZW; Lu GX; Cong XL; Xie RT; Yang HQ; Chang ZY; Sun R; Chai L; Cai MX; Zhong XJ; Zhu J; Fu D
    Oncotarget; 2017 Feb; 8(7):11896-11905. PubMed ID: 28060733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
    Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
    Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.